Αρχειοθήκη ιστολογίου

Πέμπτη 29 Ιουνίου 2017

Rare splicing defects of FAS underly severe recessive autoimmune lymphoproliferative syndrome

S15216616.gif

Publication date: Available online 29 June 2017
Source:Clinical Immunology
Author(s): N. Agrebi, I. Ben-Mustapha, N. Matoussi, N. Dhouib, M. Ben-Ali, N. Mekki, M. Ben-Ahmed, B. Larguèche, S. Ben Becher, M. Béjaoui, M.R. Barbouche
Autoimmune lymphoproliferative syndrome (ALPS) is a prototypic disorder of impaired apoptosis characterized by autoimmune features and lymphoproliferation. Heterozygous germline or somatic FAS mutations associated with preserved protein expression have been described. Very rare cases of homozygous germline FAS mutations causing severe autosomal recessive form of ALPS with a complete defect of Fas expression have been reported.We report two unrelated patients from highly inbred North African population showing a severe ALPS phenotype and an undetectable Fas surface expression. Two novel homozygous mutations have been identified underlying rare splicing defects mechanisms. The first mutation breaks a branch point sequence and the second alters a regulatory exonic splicing site. These splicing defects induce the skipping of exon 6 encoding the transmembrane domain of CD95. Our findings highlight the requirement of tight regulation of FAS exon 6 splicing for balanced alternative splicing and illustrate the importance of such studies in highly consanguineous populations.



http://ift.tt/2t4ToEJ

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου